Akari Therapeutics PLC Sustainability Reports

Akari Therapeutics PLC is a clinical-stage biotechnology company developing advanced targeted therapies, including next-generation antibody-drug conjugates (ADCs), for the treatment of cancer, autoimmune, and inflammatory diseases.

Sector: Manufacturing

Country: United Kingdom

Exchange: Nasdaq

LEI: 2138001XURASAU3MEB68

4 reports from 2019 to 2025

• Akari Therapeutics PLC 2025 Annual Report
• Akari Therapeutics PLC 2024 Annual Report and Consolidated Financial Statements
• Akari Therapeutics PLC 2023 Form 10-K
• Akari Therapeutics PLC 2019 Consolidated Annual Report and Financial Statements